{"title":"Relationship between physical performance and health-related quality of life in patients with heart failure","authors":"","doi":"10.1016/j.rccl.2023.10.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>This study aims to describe relationship between physical performance (PP) and health-related quality of life in patients with heart failure (HF).</p></div><div><h3>Methods</h3><p>This study used a cross-sectional design for data collection. Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used as a measurement tool, while the Five Times Sit-to-Stand Test (FTSST) was used to assess PP. The data were processed by Pearson correlation coefficient, <em>t</em>-test, one-way ANOVAs, and Hierarchical multiple regression.</p></div><div><h3>Results</h3><p>A total of 180 patients with HF participated in this study, with the mean age of respondents being 59.98 (11.86) years old. Among these respondents, 60% were male, with a mean PP of 9.56 (6.94)<!--> <!-->s and a mean MLHFQ of 43.14 (20.74). The results showed that MLHFQ had a significant correlation with HF medication (<em>r</em> <!-->=<!--> <!-->.16, <em>P</em> <!--><<!--> <!-->.05), health status (<em>r</em> <!-->=<!--> <!-->.24, <em>P</em> <!--><<!--> <!-->.01), FTSST (<em>r</em> <!-->=<!--> <!-->.40, <em>P</em> <!--><<!--> <!-->.01), and MLHFQ was significantly associated with New York Heart Association (NYHA) Classification (<em>F</em> <!-->=<!--> <!-->8.358, <em>P</em> <!--><<!--> <!-->.001). There were three variables identified as predictors of MLHFQ, namely health status (<em>β</em> <!-->=<!--> <!-->−2.22), NYHA Class III (<em>β</em> <!-->=<!--> <!-->1.27), and FTSST (<em>β</em> <!-->=<!--> <!-->3.03), and were predicted to account for 31.1% of the variance in MLHFQ.</p></div><div><h3>Conclusions</h3><p>Efforts to increase PP from patients with HF can be an asset to improve health-related quality of life. Furthermore, health status and NYHA classifications are factors that can significantly affect health-related quality of life of patients with HF.</p></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 3","pages":"Pages 177-183"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"REC: CardioClinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2605153223003084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and objectives
This study aims to describe relationship between physical performance (PP) and health-related quality of life in patients with heart failure (HF).
Methods
This study used a cross-sectional design for data collection. Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used as a measurement tool, while the Five Times Sit-to-Stand Test (FTSST) was used to assess PP. The data were processed by Pearson correlation coefficient, t-test, one-way ANOVAs, and Hierarchical multiple regression.
Results
A total of 180 patients with HF participated in this study, with the mean age of respondents being 59.98 (11.86) years old. Among these respondents, 60% were male, with a mean PP of 9.56 (6.94) s and a mean MLHFQ of 43.14 (20.74). The results showed that MLHFQ had a significant correlation with HF medication (r = .16, P < .05), health status (r = .24, P < .01), FTSST (r = .40, P < .01), and MLHFQ was significantly associated with New York Heart Association (NYHA) Classification (F = 8.358, P < .001). There were three variables identified as predictors of MLHFQ, namely health status (β = −2.22), NYHA Class III (β = 1.27), and FTSST (β = 3.03), and were predicted to account for 31.1% of the variance in MLHFQ.
Conclusions
Efforts to increase PP from patients with HF can be an asset to improve health-related quality of life. Furthermore, health status and NYHA classifications are factors that can significantly affect health-related quality of life of patients with HF.